Growth Metrics

Eton Pharmaceuticals (ETON) Change in Account Payables (2018 - 2025)

Eton Pharmaceuticals' Change in Account Payables history spans 7 years, with the latest figure at -$3.3 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 321.59% to -$3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 million, a 193.7% increase, with the full-year FY2025 number at $6.8 million, up 193.7% from a year prior.
  • Change in Account Payables hit -$3.3 million in Q4 2025 for Eton Pharmaceuticals, down from $2.1 million in the prior quarter.
  • Over the last five years, Change in Account Payables for ETON hit a ceiling of $7.3 million in Q2 2025 and a floor of -$3.3 million in Q4 2025.
  • Historically, Change in Account Payables has averaged $430050.0 across 5 years, with a median of $11500.0 in 2022.
  • Biggest five-year swings in Change in Account Payables: plummeted 1033.09% in 2021 and later skyrocketed 5688.46% in 2025.
  • Tracing ETON's Change in Account Payables over 5 years: stood at -$1.3 million in 2021, then soared by 156.11% to $712000.0 in 2022, then tumbled by 85.25% to $105000.0 in 2023, then surged by 1311.43% to $1.5 million in 2024, then tumbled by 321.59% to -$3.3 million in 2025.
  • Business Quant data shows Change in Account Payables for ETON at -$3.3 million in Q4 2025, $2.1 million in Q3 2025, and $7.3 million in Q2 2025.